Journal of cardiothoracic and vascular anesthesiaHumansAmyloid NeuropathiesFamilialCardiomyopathiesPrealbumin
Advances in Cardiovascular Pharmacotherapy. V. Molecular Targets in Transthyretin Amyloid Cardiomyopathy.
Paul S Pagel, Dustin Hang, Julie K Freed, George J Crystal
Published: 202510.1053/j.jvca.2025.08.006
Abstract
Transthyretin amyloid cardiomyopathy (ATTR-CM) is an infiltrative disease that occurs when the tetrameric transthyretin complex dissociates into its constituent monomers, which then misfold, aggregate, and accumulate as amyloid fibrils in the myocard…
Preview only. Read the full abstract at the source